146 related articles for article (PubMed ID: 28130401)
21. MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.
Frigola G; Bühler M; Marginet M; Enjuanes A; Nadeu F; Papaleo N; Salido M; Haralambieva E; Alamo J; Garcia-Bragado F; Álvarez R; Ramos R; Aldecoa I; Campo E; Colomo L; Balagué O
Arch Pathol Lab Med; 2023 Aug; 147(8):896-906. PubMed ID: 36355424
[TBL] [Abstract][Full Text] [Related]
22. A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis.
Hartert M; Ströbel P; Dahm M; Nix W; Marx A; Vahl CF
Am J Surg Pathol; 2010 May; 34(5):742-5. PubMed ID: 20305533
[TBL] [Abstract][Full Text] [Related]
23. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
[TBL] [Abstract][Full Text] [Related]
24. Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.
Van den Bergh JMJ; Smits ELJM; Berneman ZN; Hutten TJA; De Reu H; Van Tendeloo VFI; Dolstra H; Lion E; Hobo W
Cancer Immunol Res; 2017 Aug; 5(8):710-715. PubMed ID: 28637876
[TBL] [Abstract][Full Text] [Related]
25. [Follicular dendritic cell sarcoma: an unusual tumor with nodal and extranodal presentation. Clinicopathological and immunohistochemical study of five cases].
Jorge-Buys DL; Lastra-Camacho G; Campos-Martínez J; Romero-Guadarrama M; Ortiz-Hidalgo C
Cir Cir; 2008; 76(2):145-52. PubMed ID: 18492436
[TBL] [Abstract][Full Text] [Related]
26. Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands.
Vermi W; Giurisato E; Lonardi S; Balzarini P; Rossi E; Medicina D; Bosisio D; Sozzani S; Pellegrini W; Doglioni C; Marchetti A; Rossi G; Pileri S; Facchetti F
Clin Cancer Res; 2013 Sep; 19(18):5027-38. PubMed ID: 23888072
[TBL] [Abstract][Full Text] [Related]
27. Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
Danilova L; Wang H; Sunshine J; Kaunitz GJ; Cottrell TR; Xu H; Esandrio J; Anders RA; Cope L; Pardoll DM; Drake CG; Taube JM
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7769-E7777. PubMed ID: 27837027
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
29. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.
El Shikh ME; El Sayed RM; Szakal AK; Tew JG
J Immunol; 2009 Mar; 182(6):3482-91. PubMed ID: 19265126
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural study of highly enriched follicular dendritic cells reveals their morphology and the periodicity of immune complex binding.
Sukumar S; El Shikh ME; Tew JG; Szakal AK
Cell Tissue Res; 2008 Apr; 332(1):89-99. PubMed ID: 18236080
[TBL] [Abstract][Full Text] [Related]
31. Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas.
Spurny C; Kailayangiri S; Jamitzky S; Altvater B; Wardelmann E; Dirksen U; Hardes J; Hartmann W; Rossig C
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28868758
[TBL] [Abstract][Full Text] [Related]
32. Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.
Nowicki TS; Akiyama R; Huang RR; Shintaku IP; Wang X; Tumeh PC; Singh A; Chmielowski B; Denny C; Federman N; Ribas A
Cancer Immunol Res; 2017 Feb; 5(2):118-126. PubMed ID: 28039162
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of Ca(2+)-binding proteins on follicular dendritic cells in non-neoplastic and neoplastic lymphoid follicles.
Tsunoda T; Yamakawa M; Takahashi T
Am J Pathol; 1999 Sep; 155(3):805-14. PubMed ID: 10487838
[TBL] [Abstract][Full Text] [Related]
34. A Cytological Review of Follicular Dendritic Cell-Derived Tumors with Emphasis on Follicular Dendritic Cell Sarcoma and Unicentric Castleman Disease.
Jiménez-Heffernan JA; Díaz Del Arco C; Adrados M
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204497
[TBL] [Abstract][Full Text] [Related]
35. Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.
Byford ET; Carr M; Ladikou E; Ahearne MJ; Wagner SD
PLoS One; 2018; 13(1):e0190468. PubMed ID: 29293620
[TBL] [Abstract][Full Text] [Related]
36. Follicular dendritic cells and related sarcoma.
Facchetti F; Lorenzi L
Semin Diagn Pathol; 2016 Sep; 33(5):262-76. PubMed ID: 27318412
[TBL] [Abstract][Full Text] [Related]
37. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report.
Ren W; Sun Q; Wu PY; Huang B; Yang J; Yan J; Liu BR
Medicine (Baltimore); 2018 Nov; 97(48):e13413. PubMed ID: 30508944
[TBL] [Abstract][Full Text] [Related]
38. SSTR2a Is a Useful Diagnostic Marker for Follicular Dendritic Cells and Their Related Tumors.
Tao LL; Huang YH; Chen YL; Yu GY; Yin WH
Am J Surg Pathol; 2019 Mar; 43(3):374-381. PubMed ID: 30585825
[TBL] [Abstract][Full Text] [Related]
39. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
[TBL] [Abstract][Full Text] [Related]
40. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
Karasar P; Esendagli G
Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
